JPS60260516A - 向精神薬 - Google Patents

向精神薬

Info

Publication number
JPS60260516A
JPS60260516A JP59116524A JP11652484A JPS60260516A JP S60260516 A JPS60260516 A JP S60260516A JP 59116524 A JP59116524 A JP 59116524A JP 11652484 A JP11652484 A JP 11652484A JP S60260516 A JPS60260516 A JP S60260516A
Authority
JP
Japan
Prior art keywords
drug
active ingredient
psychotropic
compounds
psychotropic agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP59116524A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0542409B2 (https=
Inventor
Kazutoshi Horigome
堀込　和利
Masanori Fujita
正則 藤田
Akira Awaya
昭 粟屋
Takuo Nakano
中野　卓雄
Yoshiro Furuya
古屋　吉朗
Hiroyasu Ono
裕康 大野
Keiichi Yokoyama
恵一 横山
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsui Pharmaceuticals Inc
Mitsui Petrochemical Industries Ltd
Original Assignee
Mitsui Pharmaceuticals Inc
Mitsui Petrochemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsui Pharmaceuticals Inc, Mitsui Petrochemical Industries Ltd filed Critical Mitsui Pharmaceuticals Inc
Priority to JP59116524A priority Critical patent/JPS60260516A/ja
Priority to PCT/JP1985/000325 priority patent/WO1986000017A1/ja
Publication of JPS60260516A publication Critical patent/JPS60260516A/ja
Publication of JPH0542409B2 publication Critical patent/JPH0542409B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP59116524A 1984-06-08 1984-06-08 向精神薬 Granted JPS60260516A (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP59116524A JPS60260516A (ja) 1984-06-08 1984-06-08 向精神薬
PCT/JP1985/000325 WO1986000017A1 (fr) 1984-06-08 1985-06-08 Medicaments psychotropes et procede de traitement de psychoses

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59116524A JPS60260516A (ja) 1984-06-08 1984-06-08 向精神薬

Publications (2)

Publication Number Publication Date
JPS60260516A true JPS60260516A (ja) 1985-12-23
JPH0542409B2 JPH0542409B2 (https=) 1993-06-28

Family

ID=14689258

Family Applications (1)

Application Number Title Priority Date Filing Date
JP59116524A Granted JPS60260516A (ja) 1984-06-08 1984-06-08 向精神薬

Country Status (2)

Country Link
JP (1) JPS60260516A (https=)
WO (1) WO1986000017A1 (https=)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4258188A (en) * 1980-02-04 1981-03-24 American Home Products Corporation 2-(1-Piperazinyl)-cycloheptimidazole derivatives

Also Published As

Publication number Publication date
WO1986000017A1 (fr) 1986-01-03
JPH0542409B2 (https=) 1993-06-28

Similar Documents

Publication Publication Date Title
JP4925074B2 (ja) ミルタザピンと１種以上の選択的セロトニン再取り込み阻害剤とを含む医薬組成物
EP1223938A1 (en) TREATMENT OF MOVEMENT DISORDERS BY ADMINISTRATION OF 5-HYDROXYTRYPTAMINE RECEPTOR/$g(a) 2? ADRENERGIC RECEPTOR ANTAGONIST COMPOSITIONS
HU226976B1 (en) Use of pirrolidine derivatives having kappa-opium-agonist effect for the preparation of a medicament for treating of inflammatory diseases of the intestine
EP2114398B1 (en) Isosorbide mononitrate derivatives for the treatment of ocular hypertension
US3922340A (en) Pharmaceutical compositions for treating lung diseases
NO318461B1 (no) Midler til behandling av lidelser som stammer fra narkotikamisbruk
CN111479568A (zh) 司培前列素与Rho激酶抑制剂的组合药物
JP5756105B2 (ja) パーキンソン病の治療のための組成物および方法
JP7346305B2 (ja) ピリジルアミノ酢酸化合物を含有する医薬製剤
IE851848L (en) Propiophenone compound against sexual dysfunction
JPS60260516A (ja) 向精神薬
JP3066561B2 (ja) 近視予防・治療剤
US20080242657A1 (en) Treatment of Tremor with Histamine H3 Inverse Agonists or Hist Amine H3 Antagonists
US3932652A (en) Antidepressant compositions
CN111479567B (zh) 包含FP激动剂和β-阻断剂的青光眼的治疗剂
CN100502861C (zh) 抑制钠/钙交换系统的药剂
US5441962A (en) Method for treating hyperlipemia
JP2558147B2 (ja) 免疫性疾患治療剤
US7842702B2 (en) Treatment for irritable bowel syndrome
US3257277A (en) Synergistic antihypertensive compositions
WO2006041120A1 (ja) 医薬組成物
JP2004535457A (ja) ピリダジノン誘導体の新しい用途
JP2000034228A (ja) 頚椎捻挫治療剤
MXPA05009782A (es) Uso de derivados de piridin-2-ilmetilamina para la produccion de un medicamento para el tratamiento de sintomas de dolor cronico de origen neuropatologico o psicogenico.
US20020137767A1 (en) Methods for treating addictive disorders